- Home
- MREO vs BAND Comparison
MREO vs BAND Comparison
Compare MREO & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- BAND
- Stock Information
- Founded
- MREO 2015
- BAND 2000
- Country
- MREO United Kingdom
- BAND United States
- Employees
- MREO N/A
- BAND N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- BAND Computer Software: Prepackaged Software
- Sector
- MREO Health Care
- BAND Technology
- Exchange
- MREO Nasdaq
- BAND Nasdaq
- Market Cap
- MREO 424.5M
- BAND 358.3M
- IPO Year
- MREO N/A
- BAND 2017
- Fundamental
- Price
- MREO $2.41
- BAND $14.07
- Analyst Decision
- MREO Strong Buy
- BAND Hold
- Analyst Count
- MREO 7
- BAND 5
- Target Price
- MREO $7.71
- BAND $21.00
- AVG Volume (30 Days)
- MREO 1.5M
- BAND 279.4K
- Earning Date
- MREO 05-19-2025
- BAND 05-07-2025
- Dividend Yield
- MREO N/A
- BAND N/A
- EPS Growth
- MREO N/A
- BAND N/A
- EPS
- MREO N/A
- BAND N/A
- Revenue
- MREO N/A
- BAND $751,695,000.00
- Revenue This Year
- MREO N/A
- BAND $1.59
- Revenue Next Year
- MREO $56.11
- BAND $13.79
- P/E Ratio
- MREO N/A
- BAND N/A
- Revenue Growth
- MREO N/A
- BAND 18.51
- 52 Week Low
- MREO $1.58
- BAND $11.33
- 52 Week High
- MREO $5.02
- BAND $25.02
- Technical
- Relative Strength Index (RSI)
- MREO 50.36
- BAND 61.76
- Support Level
- MREO $2.28
- BAND $11.93
- Resistance Level
- MREO $2.75
- BAND $12.72
- Average True Range (ATR)
- MREO 0.16
- BAND 0.46
- MACD
- MREO -0.00
- BAND 0.30
- Stochastic Oscillator
- MREO 27.66
- BAND 91.13
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.